Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study

doi:10.1016/j.jiph.2023.09.016

CNU IR > College of Smart Living > Dept. of Hospital and Health (including master's program) > Periodical Articles > Item 310902800/34921

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34921

Title:	Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study
Authors:	Chao, Chien-Ming Lai, Chih-Cheng Chan, Khee-Siang Yang, Chun-Chieh Chen, Chin-Ming Ho, Chung-Han Ou, Hsuan-Fu Yu, Wen-Liang
Contributors:	Chi Mei Med Ctr, Dept Intens Care Med Min Hwei Coll Hlth Care Management, Dept Dent Lab Technol Chi Mei Med Ctr, Div Hosp Med, Dept Internal Med Natl Sun Yat Sen Univ, Coll Med, Sch Med Chi Mei Med Ctr, Dept Intens Care Med Chi Mei Med Ctr, Dept Med Res Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm Chi Mei Med Ctr, Dept Intens Care Med Taipei Med Univ, Coll Med, Sch Med, Dept Med Chi Mei Med Ctr, Dept Intens Care Med
Keywords:	Antifungal therapy Aspergillosis Intensive care unit Mortality Outcome
Date:	2023
Issue Date:	2024-12-25 11:05:41 (UTC+8)
Publisher:	ELSEVIER SCIENCE LONDON
Abstract:	Background: Previous studies have revealed higher mortality rates in patients of severe influenza coinfected with invasive pulmonary aspergillosis (IPA) than in those without the coinfection; nonetheless, the clinical outcome of IPA in critically ill patients without influenza remains unclear.Patients and methods: This retrospective study was conducted in three institutes. From 2016-2018, all adult patients diagnosed with IPA in the intensive care units (ICUs) were identified. The logistic regression was used to identify the potential risk factors associated with in-hospital mortality in patients with non-influenza IPA. The stratified analysis of IPA patients with and without antifungal therapy was also performed. The final model was established using a forward approach, selecting variables with p-values less than 0.05. Results: Ninety patients were included during the study period, and 63 (70%) were men. The most common comorbidity was diabetes mellitus (n = 24, 27%), followed by solid cancers (n = 22, 24%). Antifungal therapy was administered to 50 (56%) patients, mostly voriconazole (n = 44). The in-hospital mortality rate was 49% (n = 44). Univariate analysis revealed that the risk factors for mortality included daily steroid dose, APACHE II score, SOFA score, C-reactive protein (CRP) level, carbapenem use, antifungal therapy, and caspofungin use. Multiple regression analysis identified four independent risk factors for mortality: age (Odds ratio [OR], 1.052, p = 0.013), daily steroid dose (OR, 1.057, p = 0.002), APACHE II score (OR, 1.094, p = 0.012), and CRP level (OR, 1.007, p = 0.008). Furthermore, the multivariable analysis identified that more physicians would initiate antifungal therapy for patients with prolonged steroid use (p = 0.001), lower white blood cell count (p = 0.021), and higher SOFA score (p = 0.048). Thus, under the selection bias, the independent risk factors for mortality in the antifungal treatment subgroup were daily steroid dose (OR, 1.046, p = 0.001) and CRP (OR, 1.006, p = 0.018), whereas the independent risk factor for mortality in the untreated group became APACHE II score (OR, 1.232, p = 0.007).Conclusions: Patients with IPA had a substantially high mortality. Overall, age, steroid use, APACHE II score, and CRP level were identified as the independent risk factors for mortality in patients in the ICU.(c) 2023 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Relation:	Journal of Infection And Public Health, v.16, n.12, pp.2001-2009
Appears in Collections:	[Dept. of Hospital and Health (including master's program)] Periodical Articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	40	View/Open
j.jiph.2023.09.016.pdf		506Kb	Adobe PDF	13	View/Open

Loading...